The bill adds two new concepts—"eligible nurse prescriber" and "authorised nurse prescriber"—to the National Health Act 1953 and updates the Health Insurance Act 1973 so authorised nurse prescribers can both write PBS prescriptions and, in some cases, supply PBS medicines directly. The Minister will set eligibility criteria and the list of PBS items an authorised nurse prescriber may prescribe or supply by legislative instrument; approvals and conditions are handled by the Secretary.
Why it matters: the measure formalises a national route for registered nurses to take on prescribing and limited supply roles currently reserved for medical practitioners and nurse practitioners. That changes workforce responsibilities, creates new compliance and payment pathways for the PBS, and concentrates significant discretion in ministerial legislative instruments and administrative approvals.
At a Glance
What It Does
The bill creates statutory definitions for eligible and authorised nurse prescribers, requires a Ministerial legislative instrument to specify eligibility criteria and permitted PBS items, and gives the Secretary power to approve, condition, suspend or revoke authorisations. It also creates a new prescriber-bag supply power allowing authorised nurse prescribers to supply selected PBS medicines subject to Minister-set limits and regulations.
Who It Affects
Registered nurses seeking expanded scope, primary care clinics and community health services that may use nurse prescribers, general practitioners and pharmacists who interact with PBS prescribing and dispensing, and the Department/Secretary who must implement approvals and manage PBS payments.
Why It Matters
This is a structural change to who can prescribe and supply PBS-funded medicines and how the Commonwealth pays for those supplies. It reallocates clinical activity, imposes new compliance obligations on practitioners and services, and creates administrative decision-making and fiscal exposure tied to ministerial determinations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill inserts a two-step scheme into the National Health Act: first define who can be an "eligible nurse prescriber"; second allow eligible nurses to apply to the Secretary to become an "authorised nurse prescriber". A nurse becomes "eligible" only if they are a registered nurse and meet requirements that the Minister sets by legislative instrument.
The Act expressly prevents anyone from being treated as eligible if no Ministerial determination is in force.
Once eligible, a nurse may apply in writing to the Secretary for authorisation. The Secretary approves or rejects applications using criteria and conditions that the Minister may set by legislative instrument.
The statute contemplates that authorisations can carry conditions such as requiring a nurse prescriber agreement with one or more other PBS prescribers and limiting prescribing to what the collaborators could prescribe. The Secretary must notify applicants of decisions and may suspend or revoke authorisations after procedural notice; statutory timeframes govern submissions and administrative defaults, and the applicant has internal reconsideration rights under the Act with reference to administrative review protections.The bill gives authorised nurse prescribers two operational powers.
From 1 July 2026 they may write prescriptions for pharmaceutical benefits that the Minister specifies by legislative instrument. Separately, a new section lets authorised nurse prescribers supply certain PBS medicines directly (the "prescriber bag" concept), with the Minister able to set which items and the maximum quantities, and regulations able to determine how those supplies are obtained and whether the Commonwealth will pay for them.
Existing PBS record, evidence and sanction provisions are extended to include authorised nurse prescribers: evidentiary rules, entitlement letters, suspension and offence provisions are updated to capture the new authorisation status.Taken together the changes create a national administrative framework that depends heavily on two levers: Ministerial legislative instruments (to define eligibility and permitted medicines) and departmental administration (to approve, condition and police authorisations). The bill leaves operational details—exact criteria, the permitted medicine list, payment arrangements and regulatory rules—to subordinate instruments and regulations rather than embedding them in primary legislation.
The Five Things You Need to Know
The Minister must make a legislative instrument specifying the requirements for someone to be an "eligible nurse prescriber"; if no such instrument is in force, no one can be eligible.
An eligible nurse prescriber must apply in writing to the Secretary to become an "authorised nurse prescriber"; the Secretary approves or rejects using Minister-set criteria and may impose conditions on any approval.
From 1 July 2026 an authorised nurse prescriber may write prescriptions for PBS-listed medicines that the Minister determines by legislative instrument; that date is the statutory earliest prescribing start date.
Section 93AC creates a 'prescriber bag' power allowing authorised nurse prescribers to supply specified PBS medicines directly, with the Minister able to set maximum quantities and regulations able to govern payments by the Commonwealth.
Approvals can be suspended or revoked by the Secretary for failure to meet eligibility/criteria or breach of conditions; the Secretary must give written notice, allow 28 days for submissions, and is subject to internal reconsideration and Administrative Review Tribunal notification rules.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Integrate 'eligible nurse prescriber' into Health Insurance Act definitions and authorities
These amendments insert references to "eligible nurse prescribers" throughout the Health Insurance Act so that existing concepts—practitioner, profession and service definitions—explicitly capture the new nurse prescriber category. They also extend the Part VII authority language where approvals and authorisations are tracked, ensuring authorised nurse prescribers are accommodated by existing payment and entitlement machinery. Practically, this prevents administrative gaps where a nurse prescriber might otherwise fall outside current Health Insurance Act definitions.
Minister sets eligibility requirements by legislative instrument
This new section makes being a registered nurse a baseline and then delegates the rest of the eligibility criteria to a Ministerial legislative instrument, with a non-exhaustive list of possible requirements (qualifications, experience, endorsements). The provision also contains an explicit negative: without a legislative determination in force, no one qualifies. That design centralises the substance of eligibility outside the Act itself and makes the timing and scope of the policy contingent on subordinate instruments.
Secretary approves authorisations, may impose conditions, and manages suspensions with review rights
An eligible nurse prescriber applies to the Secretary to become authorised. The Secretary's approval power is constrained by criteria and conditions the Minister may determine; conditions can require nurse prescriber agreements and impose operational limits. The Secretary must decide "as soon as practicable" and notify applicants, and the Act sets procedural safeguards before suspension or revocation: written notice, reasons, a 28‑day submission window, consideration of submissions, and time limits that create a 60‑day default against suspension. The Act also provides for internal reconsideration of Secretary decisions and points to Administrative Review Tribunal notification requirements, creating a clear administrative appeals path.
Statutory prescribing power and effective date
The bill amends the sections governing who can write prescriptions so that an authorised nurse prescriber is expressly able to write prescriptions "on or after 1 July 2026" for any pharmaceutical benefit the Minister determines. This ties the operational start of nurse prescribing to that fixed date, while leaving the actual medicines and scope to the Minister's legislative instrument. The secretary/department must therefore prepare subordinate instruments and implementation steps ahead of that date to enable prescribing to commence.
Authorised nurse prescribers may directly supply selected PBS medicines subject to limits and payment rules
Section 93AC authorises authorised nurse prescribers to supply PBS medicines to eligible recipients, except where the regulations provide otherwise. The Minister may determine which pharmaceutical benefits are included and may set maximum quantities per period. The regulations may govern obtaining those supplies and whether the Commonwealth will make payments for them. Operationally this is the mechanism that allows nurse prescribers to provide medicines at point-of-care without a separate pharmacy dispense, but the payment and procurement detail is left to subordinate instruments.
Tie authorisation into existing PBS evidentiary, suspension and sanction regimes
The bill updates multiple provisions so that records, entitlement letters, suspension powers and offence provisions explicitly reference authorised nurse prescribers. For example, evidentiary provisions are expanded to accept letters signed by authorised nurse prescribers after 1 July 2026; defendants who are authorised nurse prescribers can have their approvals or supply authorities suspended; and administrative lists of authorisations are extended to include the new category. These cross‑references ensure authorised nurse prescribers are regulated under the same compliance architecture as other PBS prescribers.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Rural and remote patients — increased local access to PBS medicines where GPs are scarce, because authorised nurses can both prescribe and in some circumstances supply items directly at point-of-care.
- Registered nurses with advanced training — creates a formal career pathway and statutory authority for prescribing, subject to meeting Ministerial criteria and obtaining Secretary approval.
- Primary health clinics and community health services — can redesign care models and reduce GP prescribing bottlenecks, potentially improving throughput and continuity for chronic disease management.
- Public health administrators and health system planners — gain a policy tool for shifting prescribing capacity to nursing workforce to address access shortfalls without amending state-level registration laws immediately.
Who Bears the Cost
- The Commonwealth/PBS budget — opening the PBS to nurse prescribers and prescriber-bag supplies may increase entitlement claims and administrative payment complexity, exposing the budget to new demand patterns.
- The Department/Secretary — must build and run an approvals system, draft and manage Ministerial legislative instruments, monitor compliance, and manage suspensions and reviews, creating resourcing and IT obligations.
- General practitioners and pharmacists — may face revenue shifts (dispensing volumes, consultation mix) and new coordination burdens (nurse prescriber agreements, reconciling prescriptions and supplies).
- Registered nurses seeking authorisation — must meet whatever requirements the Minister prescribes, enter nurse prescriber agreements, keep records and comply with conditions that could restrict practice, incurring training and administrative costs.
- State and Territory regulators — will need to align or at least reconcile professional registration, scope-of-practice and medicines‑scheduling rules with the Commonwealth’s new authorisation framework, creating intergovernmental regulatory work.
Key Issues
The Core Tension
The bill balances two legitimate aims—expand access to PBS medicines by using nursing capacity versus preserve patient safety, fiscal control and coherent regulatory oversight—but resolves that balance by shifting substantive choices to Ministerial instruments and departmental administration, creating a trade-off between policy flexibility and reduced transparency, variable implementation, and added regulatory complexity.
The bill delegates most substantive choices—eligibility criteria, permitted medicines, approval criteria, conditions and supply limits—to Ministerial legislative instruments and regulations. That design enables flexibility and faster policy updates but concentrates significant policy discretion outside primary law, reducing parliamentary detail and making outcomes dependent on subordinate instruments and administrative practice.
Practically, stakeholders will need to watch instrument-making and regulation closely because the Act will be a skeleton until the Minister specifies key parameters.
Operationally, the scheme creates coordination challenges and potential gaps. Nurse prescriber agreements can be used both to enable and to constrain practice: they may protect patient safety by ensuring collaboration, but they may also function as de facto gatekeeping tools that limit independent practice.
The prescriber-bag supply route raises payment and pharmacy interface questions: will supplies be paid the same as dispensed items, how will pharmacists reconcile stock/claims, and how will maximum quantities be enforced to prevent diversion? The bill addresses suspension and review procedures but leaves monitoring, compliance metrics and enforcement resourcing to the department—areas that commonly determine whether a new authorisation regime succeeds in practice.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.